Relmada Therapeutics, Inc. (RLMD)
Total Valuation
RLMD has a market cap or net worth of $85.18 million. The enterprise value is -$48.47 million.
| Market Cap | 85.18M |
| Enterprise Value | -48.47M |
Important Dates
The last earnings date was Thursday, May 11, 2023, after market close.
| Earnings Date | May 11, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
RLMD has 30.10 million shares outstanding. The number of shares has increased by 6.01% in one year.
| Shares Outstanding | 30.10M |
| Shares Change (YoY) | +6.01% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 7.79% |
| Owned by Institutions (%) | 66.23% |
| Float | 22.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.42
| Current Ratio | 13.42 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -91.30% and return on invested capital (ROIC) is -111.50%.
| Return on Equity (ROE) | -91.30% |
| Return on Assets (ROA) | -83.10% |
| Return on Capital (ROIC) | -111.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$10.26M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.92% in the last 52 weeks. The beta is 0.16, so RLMD's price volatility has been lower than the market average.
| Beta (1Y) | 0.16 |
| 52-Week Price Change | -84.92% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 9.61 |
| Average Volume (30 Days) | 189,684 |
Short Selling Information
The latest short interest is 1.78 million, so 5.92% of the outstanding shares have been sold short.
| Short Interest | 1.78M |
| Short Previous Month | 1.84M |
| Short % of Shares Out | 5.92% |
| Short % of Float | 7.91% |
| Short Ratio (days to cover) | 11.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -151.11M |
| Pretax Income | -143.62M |
| Net Income | -143.62M |
| EBITDA | -143.62M |
| EBIT | -143.62M |
| Earnings Per Share (EPS) | -$4.77 |
Balance Sheet
| Cash & Cash Equivalents | 132.44M |
| Total Debt | n/a |
| Net Cash | 132.44M |
| Net Cash Per Share | $4.40 |
| Equity / Book Value | 125.47M |
| Book Value Per Share | 4.17 |
| Working Capital | 125.43M |
Cash Flow
| Operating Cash Flow | -100.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -100.88M |
| FCF Per Share | -$3.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -171.02% |
| FCF Yield | -120.12% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.01% |
| Shareholder Yield | -6.01% |
Analyst Forecast
The average price target for RLMD is $9.00, which is 218.02% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.00 |
| Price Target Difference | 218.02% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -46.39% |
Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:4 |